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Relative risk* of acute and chronic GVHD based on degree of high-resolution
HLA matching
Factor RR of aGVHD (95% CI) RR of cGVHD
(95% CI) (n¼79)
Grade II-IV
(n¼191)
Grade III-IV
(n¼72)
HLA match**
9-10/10 (n¼69) 1.0 1.0 1.0
6-8/10 (n¼246) 1.1 (0.7-1.8) 1.1 (0.5-2.5) 0.7 (0.3-1.5)
<6/10 (n¼89) 1.1 (0.7-2.0) 1.4 (0.6-3.3) 1.1 (0.1-2.5)
*Adjusted for age, gender match, year of transplant, number of units, CD3,
CD34 dose, ATG use, conditioning, recipient CMV status, prior aGVHD as
appropriate; **High-resolution allele match at HLA-A, -B, -C, -DRB1, and -DQ
loci; RR, relative risk; CI, conﬁdence interval
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Introduction: HLA-mismatched unrelated cord blood
transplantation (UCBT) is feasible and, in retrospective
comparative analyses, allows survival rates similar to con-
ventional unrelated HLA-matched adult-derived grafts. It is
clear that the degree of UCB HLA mismatch in patients has a
negative effect on outcomes with low-resolution HLA typing
at A, B, DR. But the impact of HLA disparity on outcomes with
high-resolution HLA typing HLA-A, -B, -C, -DR is unclear.
Patients and Methods: To determine the impact of HLA
disparity on outcomes after UCBT, We retrospectively
reviewed patients with hematologic malignancies who un-
derwent reduced intensity CBT at Toranomon Hospital from
August 2006 and December 2010 consecutively. Patients who
had prior history of transplantation,were inpoor performance
status (ECOGPS>3), had active bacterial or fungal infections at
the time of conditioning were excluded. The most frequently
used conditioning regimenswereﬂudarabine, alkylating agent
(melphalan or busulfan) with total body irradination (TBI),
tacrolimus plusmycophenolatemofetil for GVHD prophylaxis.
DNAs of 97 pairs were analysed for HLA-A, -B, -C, and -DRB1
basedonHighResolution typing. In these caseshigh resolution
typing was carried out retrospectively.
Results: For HLA-A, -B, -C, and -DR based on high resolution
typing the followingmismatch occurred: nomismatch 2(2%),
one mismatch 5(5%), twomismatch 14(14%), three mismatch
32(33%), four mismatch 28(29%), ﬁve mismatch 14(14%), six
mismatch 2(2%). The number of total nucleated cells and
CD34+ cells were not signiﬁcantly different among them.
The cumulative incidence of neutrophil recovery was
83.5% in this study population. It was higher in HLA-B
matched group than in HLA-B mismatched group ( 94.2% vs.
78.5% up to day 60, p¼0.0044), and in multivariate analysis
HLA-B mismatch was independent predictor of engraftment
(HR, 0.074; 95%CI, 0.0074-0.74; p¼0.026). Among the HLA-A,
-C, -DRB1 mismatches, the negative impact of each single
HLA allele mismatch was not signiﬁcant.
The cumulative incidence of grade II to IV aGVHD in this
study population was 52.6%. In multivariate analysis, HLA-A
mismatch (HR, 10.51; 95%CI, 1.95-56.51; p¼0.0061), and
HLA-B mismatch (HR, 51.59; 95%CI, 1.05-2520.0; p¼0.043)
were signiﬁcantly associated with high incidence of grade II-
IV GVHD.
There were no signiﬁcant difference in the cumulative
incidence of TRM, Relapse Rate and OS in this study.
Conclusion: HLA-B allele mismatch was found to have a
signiﬁcant negative impact on engraftment and II-IV aGVHD.193
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The degree of antigen-level (HLA-A, -B) and allele-level
HLA-DRB1 matching has been correlated with the risk of
acute GVHD (aGVHD) in prior studies of umbilical cord
blood transplantation (UCBT), however no impact of HLA
matching on development of chronic GVHD (cGVHD) has
been reported for 4/6-matched UCBT. To understand the
impact of high-resolution HLA allele matching at -A, -B, -C,
-DRB1 and -DQ loci on GVHD we studied 404 recipients of
single- (n¼129) and double-unit (n¼275, based on the
predominating unit) UCBT from 2000 to 2010. Overall cu-
mulative incidence of grade II-IV aGVHD, grade III-IV
aGVHD, and cGVHD was 47%, 18%, and 20%, respectively. HLA
allele-matched recipients, grouped as 9-10/10 (17%), 6-8/10
(61%), and <6/10 (22%), had a similar cumulative incidence
of grade II-IV (43% vs. 47% vs. 52%, p¼0.5) or grade III-IV
(17% vs. 16% vs. 22%, p¼0.4) aGVHD, respectively. In multi-
variable analysis HLA matching did not inﬂuence grade II-IV
and III-IV aGVHD (all p>0.5) after adjustment for the
number of units, CD3, CD34 dose, age, gender match, con-
ditioning, recipient CMV status, ATG use, and the year of
transplant (Table). Use of ATG was independently associated
with a lower risk of grade II-IV aGVHD (relative risk [RR]¼
0.5, p<0.01). Univariate difference in cumulative incidence
of cGVHD for 9-10/10 (17%), 6-8/10 (17%), and <6/10 (29%)
HLA match was confounded by age (RR¼3.4 for 18 years,
p<0.01) and prior aGVHD (RR¼2.3, p<0.01) in multivariable
analysis adjusted for CD34, CD3 dose, and the number of
cord units. No other factors inﬂuenced cGVHD or modiﬁed
the risk of HLA matching on cGVHD. Similar results were
found in a multivariable analysis for stratiﬁed single- and
double-unit UCBT. We conclude that stringent high-resolu-
tion HLA matching at -A, -B, -C, -DRB1 and -DQ loci does not
inﬂuence the incidence of acute or chronic GVHD among
recipients of UCBT.194
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